Evaluating the cost-effectiveness of cancer patient navigation programs: conceptual and practical issues.
Patient navigators-individuals who assist patients through the healthcare system to improve access to and understanding of their health and healthcare-are increasingly used for underserved individuals at risk for or with cancer. Navigation programs can improve access, but it is unclear whether they improve the efficiency and efficacy of cancer diagnostic and therapeutic services at a reasonable cost, such that they would be considered cost-effective. In the current study, the authors outline a conceptual model for evaluating the cost-effectiveness of cancer navigation programs. They describe how this model is being applied to the Patient Navigation Research Program, a multicenter study supported by the National Cancer Institute's Center to Reduce Cancer Health Disparities. The Patient Navigation Research Program is testing navigation interventions that aim to reduce time to delivery of quality cancer care (noncancer resolution or cancer diagnosis and treatment) after identification of a screening abnormality. Examples of challenges to evaluating cost-effectiveness of navigation programs include the heterogeneity of navigation programs, the sometimes distant relation between navigation programs and outcome of interest (eg, improving access to prompt diagnostic resolution and life-years gained), and accounting for factors in underserved populations that may influence both access to services and outcomes. In this article, the authors discuss several strategies for addressing these barriers. Evaluating the costs and impact of navigation will require some novel methods, but will be critical in recommendations concerning dissemination of navigation programs.
Ramsey
Scott
S
Cancer Technology Assessment Group, Translational and Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. sramsey@fhcrc.org
Whitley
Elizabeth
E
Mears
Victoria Warren
VW
McKoy
June M
JM
Everhart
Rachel M
RM
Caswell
Robert J
RJ
Fiscella
Kevin
K
Hurd
Thelma C
TC
Battaglia
Tracy
T
Mandelblatt
Jeanne
J
D003362:Cost-Benefit Analysis; D006078:Government Programs; D006297:Health Services Accessibility / Q000191:economics* / Q000458:organization & administration*; D054625:Healthcare Disparities; D006801:Humans; D009369:Neoplasms / Q000191:economics* / Q000628:therapy*; D015397:Program Evaluation
Cancer. 2003 Jan 1;97(1):134-47
12491515
J Clin Oncol. 2008 Apr 1;26(10):1684-90
18375897
Cancer. 2008 Dec 15;113(12):3391-9
18951521
Surg Oncol Clin N Am. 2005 Oct;14(4):655-69, v
16226685
J Natl Cancer Inst. 1999 Oct 6;91(19):1641-6
10511591
Pharmacoeconomics. 1998 Mar;13(3):277-88
10178653
J Clin Oncol. 2000 Sep 15;18(18):3302-17
10986064
Cancer. 2006 Mar 15;106(6):1276-85
16475208
Ethn Dis. 2002 Winter;12(1):77-86
11913611
J Clin Oncol. 2006 Mar 20;24(9):1357-62
16549830
Cancer. 1989 Jun 15;63(12):2562-9
2720605
J Natl Cancer Inst. 2007 Jan 3;99(1):14-23
17202109
Cancer. 2004 Apr 15;100(8):1595-604
15073845
Cancer. 2008 Oct 15;113(8):1999-2010
18780320
J Urban Health. 2008 Jan;85(1):114-24
17906931
JAMA. 1996 Oct 9;276(14):1172-7
8827972
Am J Gastroenterol. 2003 Sep;98(9):2078-81
14499791
Am J Public Health. 1997 Jul;87(7):1182-9
9240110
Breast Cancer Res Treat. 2003 Sep;81(1):21-31
14531494
J Am Coll Surg. 2003 Feb;196(2):180-8
12595043
Pharmacoeconomics. 2000 May;17(5):479-500
10977389
J Cancer Educ. 2006 Spring;21(1 Suppl):S11-4
17020496
Med Care. 2008 Apr;46(4):349-56
18362813
Prev Med. 2007 Jan;44(1):26-33
16962652
J Cancer Educ. 1998 Winter;13(4):213-9
9883780
Cancer. 2007 Jan 15;109(2 Suppl):359-67
17123275
Cancer. 2005 Aug 15;104(4):848-55
16010658
Expert Rev Pharmacoecon Outcomes Res. 2003 Oct;3(5):561-7
19807390
J Natl Cancer Inst. 2008 May 7;100(9):630-41
18445825
J Clin Oncol. 2003 Mar 15;21(6):1139-46
12637482
J Gen Intern Med. 1997 Sep;12(9):551-8
9294789
CA Cancer J Clin. 2004 Mar-Apr;54(2):78-93
15061598
Cancer Pract. 1995 Jan-Feb;3(1):19-30
7704057
J Natl Med Assoc. 2008 Mar;100(3):278-84
18390020
JAMA. 1996 Oct 16;276(15):1253-8
8849754
Health Policy. 1990 Dec;16(3):199-208
10109801
Can Assoc Radiol J. 2004 Jun;55(3):145-50
15237774